Association of pityriasis rosea with Human Herpesvirus-6

Authors

  • Banihashemi Mahnaz
  • Ghaffarzadegan Kamran
  • Ghiasi-Moghadam Taghi
  • Hashemzadeh Sara
  • Javidi Zari
  • Khani Fatemeh
Abstract:

Background: Pityriasis rosea (PR) is a common papulosquamousskin disorder that is suspected to have an infectious etiology.We aimed to study the role of human herpesvirus-6 (HHV-6) inthe pathogenesis of PR.Method: We used immunohistochemical (IHC) assays to detectHHV-6 in patients with PR. Fifty-one patients with PR and 35 ageand sex matched healthy control samples were enrolled in thestudy. The intensity and percentage of cell staining for HHV-6infection were evaluated and recorded.Result: The intensity of IHC staining was negative in 25 (49.01%)patients and 24 (68.58%) control samples while it was +1 in 6(11.77%) patients and 11 (31.42%) control samples, +2 in 4 (7.85%)patients and +3 in 16 (31.37%) of them. The incidence of moderateand intense staining for HHV-6 was significantly higher amongpatients with PR than the control group (P value < 0.01).Conclusion: We concluded that HHV-6 infection may play arole in some patients with PR. The rate of HHV-6 infection wassignificantly higher in PR patients than the control group.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei.

BACKGROUND AND PURPOSE Pityriasis rosea (PR) is a common papulosquamous skin disease with unknown etiology. The possible relationship of PR with human herpesvirus infection (HHV) has been extensively studied. This study used the polymerase chain reaction (PCR) to investigate the presence of human herpesvirus 6 and 7 (HHV-6 and HHV-7) in 41 PR patients from two hospitals in Northern Taiwan. The ...

full text

Pityriasis rosea is not associated with human herpesvirus 7.

OBJECTIVE To examine the proposed association between pityriasis rosea and human herpesvirus 7 (HHV-7). DESIGN A retrospective cross-sectional survey. SETTING University medical center in Switzerland. PATIENTS Thirteen patients with pityriasis rosea and 14 persons with normal skin (control subjects). MAIN OUTCOME MEASURES Detection of HHV-7-specific DNA sequences and antigen (85-kd phos...

full text

Pityriasis rosea.

T HE Medical Research Council's investigation into pityriasis rosea in 1959 has already been published (Proc. roy. Soc. Med., 55, 556). This second investigation, based on a very simple questionnaire, has produced some additional information, but has not altogether solved the question put, namely "What is the cause of this disease?" Much interest was shown. In 1964, 180 observers notified 531 c...

full text

Pityriasis Rosea (Pityriasis Rosea Gibert) in Children — Symptoms and Treatment

Pityriasis rosea (PR) is a common skin eruption in children that is characterized by a single skin patch that usually evolves into a widespread exanthem after one week. The duration of PR is typically six weeks and the condition is selflimited with excellent prognosis. The diagnosis is established by proper history taking and physical examination of the skin lesions. Laboratory investigations a...

full text

Pityriasis Rosea (Pityriasis Rosea Gibert) in Children — Symptoms and Treatment

Pityriasis rosea (PR) is a common skin eruption in children that is characterized by a single skin patch that usually evolves into a widespread exanthem after one week. The duration of PR is typically six weeks and the condition is selflimited with excellent prognosis. The diagnosis is established by proper history taking and physical examination of the skin lesions. Laboratory investigations a...

full text

Pityriasis rosea following human papillomavirus vaccination.

We read with great interest the review by Gonçalves et al.1 about safety, tolerability and side effects of human papillomavirus (HPV) vaccines, discussing the most frequently reported events related to the vaccine. We agree that safety is not a major barrier to vaccination since most of the reported adverse events have been mild or moderate in intensity. We would like to describe two patients w...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 17  issue 4

pages  122- 125

publication date 2014-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023